The human pathogen Escherichia coli O157:H7 is thought to be spread by direct or indirect contact with infected animal or human faeces. The present study investigated the effects of the plant coumarin esculin and its aglycone esculetin on the survival of a strain of E. coli O157 under gut conditions. The addition of these compounds to human faecal slurries and in vitro continuous-flow fermenter models simulating conditions in the human colon and rumen caused marked decreases in the survival of an introduced strain of E. coli O157. When four calves were experimentally infected with E. coli O157 and fed esculin, the pathogen was detected in five of twenty-eight (18 %) of faecal samples examined post-inoculation, compared with thirteen of thirty-five (37 %) of faecal samples examined from five control calves not fed esculin. Coumarin compounds that occur naturally in dietary plants or when supplemented in the diet probably inhibit the survival of E. coli O157 in the gut.
Escherichia coli O157:H7 has emerged as a serious foodborne pathogen in the UK and other developed countries over the past 20 years. Human infection can result from the ingestion of as few as 100 viable bacterial cells (Griffin & Tauxe, 1991) and commonly results in bloody diarrhoea and haemorrhagic colitis. Potentially fatal extra-intestinal complications may occur, particularly in the young and the elderly, resulting in haemolytic uraemic syndrome and thrombolytic thrombocytopenic purpurea (Griffin & Tauxe, 1991) . The gut of herbivorous ruminant animals such as cattle and sheep is the main reservoir of E. coli O157 and transmission to man occurs principally through contamination of the food chain, or of the environment, by faeces from infected animals (Kudva et al. 1998) . Except in neonates (Dean-Nystrom et al. 1998) , carrier animals usually do not show outward evidence of disease. Faeco-oral transmission is also a significant factor in the spread of this pathogen in human populations. From studies in Wales, Parry & Salmon (1998) calculated a household transmission rate of about 7 %.
Antibiotic therapy of E. coli O157 infection is controversial since it has been associated with an increased risk of haemolytic -uraemic syndrome (Wong et al. 2000) and, in some instances, appears to increase the risk of secondary infection (Neill, 1998) . Furthermore, the use of antibiotics as growth promoters in animal husbandry is accompanied by an unacceptable risk of enhancing the spread of resistance genes (Flint et al. 1987; Barbosa & Levy, 2000; Shoemaker et al. 2001) . Alternative approaches for controlling the shedding of E. coli O157 in sheep and cattle include the use of probiotics (Zhao et al. 1998 ) and dietary manipulation, for example, decreasing the amount of cereal grains fed to animals (Diez-Gonzalez et al. 1998) . Plant coumarins are known to inhibit the growth of E. coli O157 (Duncan et al. 1998) . These plant metabolites are found in grassland herbage and may occur commonly in the free state and as glycosides (Murray et al. 1982) . Duncan et al. (1998) showed that coumarin inhibited the growth of E. coli O157 in pure culture and in batch-culture incubations of rumen contents. Under the conditions used, the coumarins had relatively minor effects on the predominant anaerobic faecal microflora.
The fermentative compartments of the gut, including the rumen and colon of sheep and cattle and the human colon, are populated predominantly by anaerobes which produce SCFA, carbon dioxide, methane and water by fermentation (Hungate, 1966) . The population density of anaerobic bacteria ranges from about 10 8 to 10 11 viable cells/ml depending on the gut site, the nature of the diet and the time elapsed after the ingestion of food (Wolin, 1981; Wilson, 1997; Russell & Rychlik, 2001) . E. coli and other facultative bacteria normally comprise between 0·01 and 1 % of the total bacterial population of the gut (Hungate, 1966; Wilson, 1997) . E. coli O157 colonises the rumen and colon of naturally infected ruminants. In cattle at slaughter at abattoirs in England, the incidence of E. coli O157 and the numbers of commensal E. coli were higher in the colon than in the rumen (Laven et al. 2003) . Nonetheless it is clear that, following ingestion, E. coli O157 must pass though the rumen and the other gut compartments before colonising the lower gastrointestinal tract. Control measures aimed at reducing the survival of E. coli O157 in the rumen and colon may be useful in ultimately reducing shedding rates amongst animals.
Here we report the effects of the plant coumarin esculin and its aglycone esculetin on the survival of E. coli O157 in human faecal slurries, fermenter models simulating conditions in the human colon and in the rumen, and the effect on faecal shedding following the experimental infection of calves.
Materials and methods
Escherichia coli strains, growth conditions, inocula preparation and tracking E. coli serogroup O157 (NCTC 12900) used in the present study (12900) does not carry verocytotoxin genes or an inducible lambdoid prophage (James et al. 2001) . Thus the laboratory and animals studies such as those described in the present paper can be performed at Health and Safety Executive category 2 instead of category 3 level of containment. Access to the latter facilities is limited in the UK, reducing the opportunity for relevant investigations. Cultures were routinely grown in Luria Bertani (LB) broths (Sambrook et al. 1982 ) (5 ml) in glass Hungate tubes (Bellco Glass Inc., Vineland, NJ, USA). E. coli O157 (12900) was grown for the inoculation of the colon-simulating fermenter in 100 ml volumes of LB medium at 378C for 18 h in a shaking incubator (150 rpm). Cultures were centrifuged at 2500 g for 15 min and washed in sterile anaerobic phosphate buffer (APB; 50 mM) containing 0·5 % (w/v) cysteine HCl as a reducing agent and prepared under O 2 -free CO 2 . Pelleted cells were re-suspended in 10 ml APB and inoculated through a port into the fermenter vessel, then washed through with a further 10 ml sterile buffer.
For inoculation of the rumen fermenters, frozen stock solutions of E. coli O157 (12900) were inoculated anaerobically into 10 ml broths of M2GSC medium (Miyazaki et al. 1997) and incubated for 24 h in an orbital shaking incubator (100 rpm, 37^18C). A sample of 500 ml of the culture was used to inoculate the rumen fermenters. The culture was inoculated through a port into the fermenter vessel.
For the experiments with calves, a rifampicin-resistant mutant of E. coli O157 (12900) was created by sub-culturing the strain in increasing concentrations of rifampicin. Single colonies were tested for growth in broth medium containing either 75 or 100 mg rifampicin/ml. The E. coli O157 rifampicin-resistant mutant (12900 R ) was maintained on LB agar plates containing 75 mg rifampicin/ml.
Selective counting of bacterial groups
Anaerobic, facultative anaerobic and faecal coliform bacteria were enumerated during E. coli O157 survival experiments. Decimal serial dilutions of samples were prepared in 9 ml anaerobic diluting fluid or 900 ml PBS. Total anaerobic bacteria were enumerated on roll tubes (Bryant, 1972) of M2GSC medium containing 2·0 % (w/v) agar. Total facultative counts were made on Nutrient agar (Oxoid, Basingstoke, Hants, UK). The total coliforms were enumerated on MacConkey agar. E. coli O157 cells were enumerated on sorbitol MacConkey agar supplemented with cefixime tellurite (CT-SMAC; Oxoid, Basingstoke, Hants, UK) as described by Chapman & Siddons (1996) or on Rainbow agar (Biolog Inc., Hayward, CA, USA). Roll tubes were incubated for 72 h and the plates for 48 h at 388C.
Effect of esculin and esculetin on survival of Escherichia coli O157 on incubation with human faeces
A faecal slurry (10 % (w/v) final concentration) was prepared by suspending freshly voided faeces from a healthy vegetarian adult male (50 years old) in anaerobic 50 mM-APB. Hungate culture tubes containing 10 % faecal slurry (9·75 ml) were inoculated with 100 ml E. coli O157 (12900) that had been incubated for 18 h at 388C and then incubated at 388C under O 2 -free CO 2 . Sub-samples (100 ml) were removed for enumeration at intervals as recorded later (p. 751). Esculin and esculetin were prepared as 1 M stock solutions in 80 % (v/v) dimethyl sulfoxide (DMSO) and appropriate levels were added to give final concentrations of 5 mM. The appropriate levels of DMSO were added to the control tubes. The incubations were conducted as three replicates for each treatment and counts were the average of three replicates at 24 h intervals for a period of 72 h.
Effect of esculetin on survival of Escherichia coli O157 in a simulation of human colonic fermentation
A continuous-flow single-stage fermenter based on the system of Macfarlane et al. (1989) was used to model human colonic fermentation. The working volume was 900 ml, the temperature was maintained at 378C and the pH was maintained between 6·5 and 6·8. Anaerobiosis was maintained by means of a stream of O 2 -free CO 2 into the head of the medium vessel, and N 2 into the fermenter vessel as described by Scott et al. (1998) . The medium used contained xylan, amylopectin, arabinogalactan, pectin, potato starch, peptone water (Unipath, Basingstoke, Hants, UK), and haemin, bile salts and minerals (Macfarlane et al. 1989 ) with (per litre) 3·0 g NaHCO 3 , 0·5 g cysteine HCl and 0·5 ml antifoam A (Sigma, Poole, Dorset, UK). The medium turnover rate for the fermenter vessel was 1/ d, corresponding to a dilution rate of 0·042/h. The vessel was inoculated with a faecal suspension of 10 g freshly voided faeces, from a healthy adult male, suspended in 50 mM-APB (40 ml). Esculetin in 80 % (v/v) DMSO was added to the test vessel and the feed flask to give a final concentration of 10 mM-esculetin and 1·6 % (v/v) DMSO.
DMSO only was added to the control vessel and feed flask to give the same final concentration.
Rumen fermenter simulations
Rumen-simulating fermenters were set up using an apparatus similar to that of Teather & Sauer (1988) , but with a reduced working volume of 550 ml. Inoculum was prepared from the rumen contents from three cannulated sheep fed a general-purpose diet (McKain et al. 1992) . The rumen contents were pooled, diluted 1:1 with artificial saliva (McDougall, 1948) and 550 ml was added to duplicate fermenters. The general-purpose diet (5 g), which had been ground to pass through a 1 mm dry mesh, was added to the fermenter vessel once daily for the first 3 d and thereafter twice daily. The turnover rate of the fermenter contents was approximately 1·5/d. E. coli O157 (12900) was added to the fermenter contents to give 3·5 £ 10 4 colony-forming units (cfu)/ml. Esculin in 80 % (v/v) DMSO was prepared as for the human colonic fermenter and was added to the test vessel on the fourth day. Viable counts were performed as described earlier (p. 750) to determine the population of total anaerobes, total facultative anaerobes and total coliforms. E. coli O157 cells were enumerated using Rainbow agar. The fermenters were maintained for 7 d (4 d of testing) and the experiment was repeated using the rumen contents from the same sheep.
Effect of feeding esculin on faecal shedding of Escherichia coli O157 in experimentally infected calves
Friesian-Holstein male calves, 3-4 months of age, were randomly allocated to two treatment groups. The calves were housed indoors in individual pens on concrete floors bedded with wood shavings that were cleaned out daily. A proprietary calf mix was fed twice daily, with the addition of 50 g esculin sprinkled on the diet in the case of the esculin-treated group.
Before the experiment began, the palatability of esculin was confirmed by feeding a calf 50 g esculin powder in 20 kg feed. Animals to be included in the experiment were first confirmed negative for the faecal excretion of E. coli O157 and rifampicin-resistant E. coli. On days 1 and 2 all ten calves were administered 10 ml of overnight LB culture containing approximately 1 £ 10 9 cfu of the rifampicin resistant E. coli O157 (strain 12900 R )/ml. Five of these animals received esculin in their normal feed on days 1 to 5 inclusively. One of the animals in the group receiving esculin was found to have an unrelated gut malfunction and, as a result, was withdrawn from the experiment. Fresh faecal samples were collected in the morning and transported to the laboratory in chilled containers within 24 h. E. coli O157 (12900 R ) cells were enumerated on MacConkey agar containing 50 mg rifampicin/ml. Representative rifampicin-resistant colonies were sub-cultured onto MacConkey sorbitol agar and tested with E. coli O157 latex test kit (Oxoid, Basingstoke, Hants, UK) to confirm that they were E. coli O157 and not spontaneous E. coli rifampicin-resistant mutants.
Short-chain fatty acid analysis by gas chromatography SCFA were analysed as described by Richardson et al. (1989) , except that the derivatisation conditions were modified so that 800 ml diethyl ether extract was treated with 100 ml N-methyl-N-t-butyldimethylsilyltrifluoroacetimide.
Results

Batch incubations with human faeces in vitro
Anaerobic batch cultures of 10 % (w/v) human faecal slurry (final concentration), inoculated with E. coli O157 with or without the addition of esculin or esculetin, were assessed for the survival of total anaerobes, total coliforms and E. coli O157. The numbers of coliforms fell by approximately 10-fold in the controls but by more than 1 000-fold in the presence of the plant metabolites ( Fig. 1  (a) ). Most significantly, the numbers of E. coli O157 cells fell sharply in the presence of the plant metabolites. After 72 h incubation there was a decrease of over 1000fold in the numbers of E. coli O157 cells compared with the control incubations and a decrease of more than 10 000-fold compared with the initial count ( Fig. 1 (b) ).
During 72 h incubation, the number of anaerobes fell by about 50 % in the controls, 75 % in the presence of esculetin, and 90 % in the presence of esculin ( Fig. 1 (a) ). The total SCFA concentrations at the end of the incubations for the control, esculetin-and esculin-containing batch cultures were (n 3): 43·0 (SD 5·1), 39·5 (SD 0·5) and 55·85 (SD 0·7) mM respectively. The final pH values of these incubations were 6·35 (SD 0·05) (control), 6·37 (SD 0·02) (esculetin) and 6·21 (SD 0·01) (esculin).
Human colon-simulating fermenters
A model system designed to simulate human colonic fermentation (378C, pH 6·5, dilution rate 0·04/h) was used to study the effect of esculetin on the survival of E. coli O157 in the presence of human faecal bacteria in continuous culture.
In experiment 1, E. coli O157 was introduced on day 7 and esculetin (10 mM) was added on day 21 (Fig. 2) . Between days 11 and 21, before the addition of esculetin, the average number of E. coli O157 present was 6·5 (SD 0·5) £ 10 3 cfu/ml (n 10). Following the addition of esculetin the numbers of E. coli O157 dropped to about 4·4 (SD 1·6) £ 10 1 cfu/ml (n 5) between days 26 and 31. Application of the t test showed that the population of E. coli in the control period (days 11 to 21) differed significantly from that during the esculetin-feeding period (26 to 31 d) (P, 0·001). When E. coli O157 was re-introduced in the presence of esculetin on day 31, its numbers fell sharply to below 10 2 cfu/ml by day 38 (Fig. 3) . There was no evidence of an effect of esculetin on the numbers of anaerobic bacteria or of total coliforms (Fig. 2) .
The results of a second experiment, in which test and control fermenters were run simultaneously with and without esculetin in the medium, are shown in Fig. 3 . The reduction in the number of E. coli O157 in the fermenter treated with esculetin was significantly greater than that in the control vessel. Linear regression analysis (Genstat; Lawes Agricultural Trust, Harpenden, Herts, UK) was used to determine the survival of E. coli O157 in the control fermenter compared with the esculetin-fed fermenter.
ANOVA over time was used to compare the decline in numbers of E. coli O157 (12900) between the control and treatment vessels and this gave a value of P¼ 0·004. As in the previous experiment shown in Fig. 3 , esculetin did not appear to affect the total numbers of anaerobes and coliforms. The mean concentration of SCFA in representative samples taken during the study was 56·9 (SD 4·6) mM (n 15); adding esculetin to the medium did not significantly change SCFA formation (average 59·2 (SD 5·4) mM; n 15). The molar proportions of the three major SCFA acetate, propionate and butyrate averaged about 4:2:1 throughout the study and were not significantly affected by the presence of esculetin (data not shown).
Rumen-simulating fermenter E. coli O157 (12900) was added to duplicate rumen fermenter vessels and allowed to stabilise for 4 d before the addition of esculin to one vessel. The initial inoculum of E. coli O157 was 3·5 £ 10 4 cfu/ml but the number increased in the first 4 d to an average of 1·2 £ 10 6 cfu/ ml. This number was maintained for the remainder of the experiment in the control vessels but, in the test vessels, the number of E. coli O157 (12900) decreased after the addition of esculin to a minimum of 4·8 £ 10 1 cfu/ml by day 6 (Fig. 4) .
In the test vessels, the numbers of anaerobic bacteria increased for the first 2 d following the addition of esculin compared with the control (days 4 and 5) to 7·4 £ 10 9 cfu/ ml and thereafter declined slightly for the remainder of the experiment. The total number of coliforms in the test and control vessels was similar throughout (data not shown).
The initial SCFA concentrations in both fermenter vessels decreased slightly from 45 mM over the first 4 d during stabilisation. Following the addition of esculin, the total SCFA concentration in the test vessel increased to approximately 50 mM, a level greater than that in the Fig. 2 . Numbers of anaerobic bacteria (K), total coliforms ( £ ) and Escherichia coli O157 (X) in a continuous-flow fermenter simulating human colonic fermentation. Mixed human faecal bacteria were introduced on day 0, and E. coli O157 on days 7 and 31. Esculetin (E; final concentration 10 mM) was added to the fermenter contents and the medium on day 21. (···), Washout rate. control fermenter over the same period of time (data not shown). As expected, acetic acid was the major SCFA followed by propionic acid, then butyric acid.
Calf feeding trial
Before the experiment began it was demonstrated that calves accepted esculin when it was mixed throughout their solid feed at a concentration of 0·8 g esculin/kg feed. Throughout the experiment no deleterious effect on the health of the animals was observed. None of the animals were excreting E. coli O157 or rifampicin-resistant E. coli. In the 8 d following the first administration, E. coli O157 (12900 R ) was detected in 37 % of faecal samples from the control group compared with 20 % of samples from the esculin-fed group. The faecal excretion of E. coli (total coliform count including all serogroups) was highest on days 2 and 3 (data not shown). E. coli O157 (12900 R ) was excreted by all five animals in the control group on day 3 compared with two out of four of the esculin-fed group, although the number of E. coli O157 (12900 R ) in positive samples was similar in both groups. One animal in the control group continued to excrete low levels of E. coli O157 (12900 R ) up until day 9.
Discussion
In both the rumen and human colonic ecosystems the predominant bacteria belong to the low G þ C Gram-positive phylum, including many members of clostridial groups, accompanied by Bacteroides and Prevotella species of the Cytophaga -Flexibacter -Bacteroides phylum of Gram-negative bacteria (Franks et al. 1998; Suau et al. 1999; Tajima et al. 1999; Ramsak et al. 2000; Pryde et al. 2002) . The ability to hydrolyse esculin to the aglycone esculetin is a common feature of many of these organisms that possess b-glucosidase activities (Duncan, 2001) .
The recognition of the role of farm animals as a potential reservoir of E. coli O157 (Rasmussen et al. 1993 ) has focused attention on how the survival of E. coli in the gastrointestinal tract might be influenced by the diet. E. coli is known to be sensitive to SCFA produced in fermentative gut compartments such as the rumen and colon (Wolin, 1969; Wallace et al. 1989) . Diez-Gonzalez et al. (1998) hypothesised that the differences seen in the shedding of E. coli O157 by ruminants fed hay or grain might result from differences in the amounts of SCFA produced in the gut. It was argued that when grain is fed, E. coli strains in the rumen, including E. coli O157, become acid habituated, increasing survival during passage through the acid secretions of the ruminant stomach. Duncan et al. (1998) found that SCFA and plant coumarins showed additive effects in the inhibition of growth of E. coli O157. Thus, feeding diets rich in such plant secondary compounds might reduce the population size of E. coli O157 in the rumen and colon, where SCFA concentrations are high.
Naturally derived plant compounds provide a potentially simple and acceptable way to control the incidence and spread of E. coli O157 within farm animals. Whilst the potential for the expression of antimicrobial activity by plant secondary compounds in ruminant feeds is well documented (Van Soest, 1994) , much of this work has concerned effects on the indigenous populations of anaerobes that inhabit the ruminant gastrointestinal tract. It is recognised that this microbial community is influenced by a range of plant secondary compounds, including tannins, saponins (Wallace et al. 1994) , phenolic acids (Chesson et al. 1982) , essential oils (Nagy & Tengerdy, 1968) , alkaloids and coumarins (Moniello et al. 1996) . The screening of plants or their compounds for antibacterial effects on E. coli O157 or other pathogens has been performed mainly using food plants or their constituents such as tea catechins (Toda et al. 1989 ) and essential oils (Hammer et al. 1999) . However, surveys of the shedding of E. coli O157 by cattle in the USA have shown negative associations between shedding and the feeding of clover and of cottonseed, leguminous plants that contain a particularly rich variety of secondary plant compounds (Rasmussen et al. 1999) . A dietary regimen including periods in which sheep were fed sagebrush grass, which contains essential oils with antibacterial properties, has been shown to reduce the shedding of E. coli O157 by sheep (Kudva et al. 1995) .
The present study confirmed that esculin and esculetin maintained their inhibitory activity towards a strain of E. coli O157 when tested in both human colon-and rumen-simulating fermenter systems over a period of weeks. There was no indication of adaptation of the test strain, E. coli O157 (12900), during this time. These data suggest that a dietary supplement of esculin might reduce the numbers of E. coli O157 in the animal gut. They further suggest that the effect may be specific to the E. coli serogroup O157 while the overall coliform numbers were unaffected, which suggests that the mode of action has some strain-or serotype-based specificity. Genome sequencing shows that E. coli O157 differs in its gene complement to other E. coli (Ohnishi et al. 1999) ; it would not therefore be surprising if these genetic differences altered the susceptibility of the bacteria to specific inhibitors. The human colon fermenter medium used here was relatively rich in fermentable carbohydrate, whereas the rumen fermenter was supplied with mineral salts and received periodic 'feeds' of a pelleted sheep ration. In the rumen fermenter studies, the addition of esculin to the fermenter resulted in an increase in the total numbers of viable anaerobes. Esculin hydrolysis releases glucose, providing a growth substrate for anaerobes and resulting in enhanced SCFA levels which may have contributed to the decreased survival of E. coli O157.
In calves, the effect of esculin did not reach statistical significance. The results are nonetheless encouraging, as E. coli was detected less frequently in the esculin-fed group. The use of the marked rifampicin-resistant E. coli O157 strain (12900 R ) and antibiotic selection agar in the animal studies allowed the detection of low levels of the organism in faecal samples.
Given the scarcity of the facilities for experiments with animals and the complex ethical issues involved, the in vitro model systems used in the present study can provide conditions similar to those in the gut, particularly in relation to turnover time and pH. They thus offer an alternative to batch incubations for the assessment of the possible effects of dietary additives on the survival of pathogens.
Recent observations on the distribution of E. coli O157 in cattle at slaughter suggest that the colon is an important habitat for this bacterium (Laven et al. 2003) . For maximum protective effect, it may be necessary to ensure that compounds or treatments intended to inhibit the growth and survival of E. coli O157 reach the large bowel, perhaps by the use of timed-release encapsulation or other methods. More knowledge of the ecology of E. coli O157 in the digestive tract will help to improve nutritional strategies to reduce the incidence of this pathogen in farm animals.
